Edwin Charles Gravereaux, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Aneurysm, Abdominal | 12 | 2022 | 1199 | 0.460 |
Why?
|
| Stents | 11 | 2016 | 3303 | 0.350 |
Why?
|
| Vascular Surgical Procedures | 7 | 2019 | 1469 | 0.340 |
Why?
|
| Endarterectomy, Carotid | 1 | 2014 | 560 | 0.310 |
Why?
|
| Blood Vessel Prosthesis Implantation | 7 | 2022 | 1426 | 0.270 |
Why?
|
| Carotid Stenosis | 1 | 2014 | 872 | 0.270 |
Why?
|
| Graft Occlusion, Vascular | 3 | 2024 | 560 | 0.270 |
Why?
|
| Angioplasty | 3 | 2002 | 360 | 0.240 |
Why?
|
| Aortic Aneurysm, Thoracic | 4 | 2015 | 693 | 0.240 |
Why?
|
| Peripheral Vascular Diseases | 3 | 2004 | 515 | 0.240 |
Why?
|
| Peripheral Arterial Disease | 3 | 2024 | 1305 | 0.220 |
Why?
|
| Lithotripsy | 1 | 2023 | 142 | 0.200 |
Why?
|
| Blood Vessel Prosthesis | 6 | 2003 | 945 | 0.190 |
Why?
|
| Intermittent Claudication | 3 | 2016 | 305 | 0.190 |
Why?
|
| Spinal Cord Ischemia | 1 | 2001 | 93 | 0.180 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 1064 | 0.160 |
Why?
|
| Aortography | 3 | 2015 | 419 | 0.150 |
Why?
|
| Iliac Artery | 4 | 2003 | 344 | 0.150 |
Why?
|
| Popliteal Artery | 3 | 2016 | 312 | 0.150 |
Why?
|
| Angioplasty, Balloon | 2 | 2016 | 597 | 0.140 |
Why?
|
| Emergencies | 2 | 2021 | 1217 | 0.140 |
Why?
|
| Endovascular Procedures | 3 | 2022 | 2135 | 0.130 |
Why?
|
| Ischemia | 4 | 2016 | 1893 | 0.130 |
Why?
|
| Anatomy | 1 | 2017 | 126 | 0.130 |
Why?
|
| Intraoperative Care | 1 | 2019 | 768 | 0.130 |
Why?
|
| Femoral Artery | 3 | 2016 | 831 | 0.120 |
Why?
|
| Aorta, Abdominal | 2 | 2015 | 622 | 0.120 |
Why?
|
| Embolization, Therapeutic | 1 | 2023 | 1411 | 0.110 |
Why?
|
| Limb Salvage | 3 | 2024 | 466 | 0.110 |
Why?
|
| Endoleak | 1 | 2013 | 105 | 0.110 |
Why?
|
| Arteries | 2 | 2011 | 1126 | 0.100 |
Why?
|
| Stroke | 1 | 2014 | 9945 | 0.100 |
Why?
|
| Angiography | 5 | 2016 | 1605 | 0.090 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2005 | 752 | 0.090 |
Why?
|
| Lower Extremity | 2 | 2016 | 1196 | 0.090 |
Why?
|
| Cardiology | 1 | 2021 | 1723 | 0.090 |
Why?
|
| Endothelial Growth Factors | 2 | 2003 | 674 | 0.080 |
Why?
|
| Brachytherapy | 1 | 2016 | 1240 | 0.080 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 822 | 0.080 |
Why?
|
| Aneurysm, False | 1 | 2011 | 257 | 0.080 |
Why?
|
| Leg | 2 | 2004 | 1091 | 0.080 |
Why?
|
| Cerebral Angiography | 1 | 2014 | 1272 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 2544 | 0.070 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 1109 | 0.070 |
Why?
|
| Prosthesis Failure | 2 | 2003 | 1206 | 0.070 |
Why?
|
| Treatment Outcome | 13 | 2023 | 64947 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3598 | 0.070 |
Why?
|
| General Surgery | 1 | 2017 | 1681 | 0.070 |
Why?
|
| Inguinal Canal | 1 | 2005 | 72 | 0.060 |
Why?
|
| Ultrasonography, Doppler, Duplex | 2 | 2016 | 200 | 0.060 |
Why?
|
| Iliac Vein | 1 | 2004 | 70 | 0.060 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 2063 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2015 | 20484 | 0.060 |
Why?
|
| Risk Factors | 8 | 2024 | 74269 | 0.050 |
Why?
|
| Carotid Artery, Common | 1 | 2003 | 177 | 0.050 |
Why?
|
| Vascular Patency | 3 | 2016 | 901 | 0.050 |
Why?
|
| Vascular Grafting | 1 | 2024 | 153 | 0.050 |
Why?
|
| Knee Joint | 1 | 2011 | 1662 | 0.050 |
Why?
|
| Saphenous Vein | 1 | 2005 | 538 | 0.050 |
Why?
|
| Endoscopy | 2 | 2002 | 1841 | 0.050 |
Why?
|
| Follow-Up Studies | 12 | 2015 | 39254 | 0.050 |
Why?
|
| Cholecystitis | 1 | 2002 | 181 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3696 | 0.050 |
Why?
|
| Iliac Aneurysm | 1 | 2001 | 37 | 0.050 |
Why?
|
| Vascular Fistula | 1 | 2001 | 50 | 0.050 |
Why?
|
| Time Factors | 9 | 2022 | 40133 | 0.050 |
Why?
|
| Viscera | 1 | 2002 | 138 | 0.050 |
Why?
|
| Lymphatic System | 1 | 2003 | 254 | 0.050 |
Why?
|
| Paraplegia | 1 | 2001 | 162 | 0.050 |
Why?
|
| Aged | 20 | 2024 | 168995 | 0.050 |
Why?
|
| Cholelithiasis | 1 | 2002 | 408 | 0.050 |
Why?
|
| Intestinal Fistula | 1 | 2001 | 143 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2014 | 3201 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2011 | 1367 | 0.040 |
Why?
|
| Male | 22 | 2024 | 359413 | 0.040 |
Why?
|
| Morbidity | 2 | 2001 | 1765 | 0.040 |
Why?
|
| Postoperative Complications | 6 | 2022 | 15680 | 0.040 |
Why?
|
| Humans | 31 | 2024 | 760261 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2001 | 544 | 0.040 |
Why?
|
| Female | 22 | 2024 | 391011 | 0.040 |
Why?
|
| Blood Cells | 1 | 2000 | 305 | 0.040 |
Why?
|
| Aortic Aneurysm | 1 | 2003 | 646 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2015 | 1215 | 0.040 |
Why?
|
| Carotid Artery Diseases | 1 | 2003 | 881 | 0.040 |
Why?
|
| Lymphokines | 1 | 2000 | 929 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 10340 | 0.030 |
Why?
|
| Steroids | 1 | 2001 | 928 | 0.030 |
Why?
|
| Lymphedema | 1 | 2003 | 525 | 0.030 |
Why?
|
| Polymers | 1 | 2023 | 1620 | 0.030 |
Why?
|
| Drainage | 1 | 2001 | 1161 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2003 | 1335 | 0.030 |
Why?
|
| Aortic Diseases | 1 | 2001 | 736 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 2002 | 1097 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2000 | 1204 | 0.030 |
Why?
|
| Retreatment | 1 | 2016 | 600 | 0.030 |
Why?
|
| Syndrome | 1 | 2021 | 3278 | 0.030 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2015 | 334 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2019 | 934 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2024 | 80301 | 0.030 |
Why?
|
| Aorta | 1 | 2021 | 2042 | 0.030 |
Why?
|
| Cadaver | 1 | 2017 | 1345 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2016 | 1098 | 0.030 |
Why?
|
| Comorbidity | 3 | 2002 | 10552 | 0.030 |
Why?
|
| Video Recording | 1 | 2017 | 957 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2019 | 1500 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2001 | 1799 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2003 | 4560 | 0.020 |
Why?
|
| Equipment Design | 2 | 2015 | 3520 | 0.020 |
Why?
|
| Middle Aged | 10 | 2024 | 220175 | 0.020 |
Why?
|
| Obesity | 1 | 2014 | 12915 | 0.020 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 15273 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2015 | 4044 | 0.020 |
Why?
|
| Renal Artery | 2 | 2002 | 368 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 12281 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2001 | 8551 | 0.020 |
Why?
|
| Probability | 2 | 2005 | 2476 | 0.020 |
Why?
|
| Netherlands | 1 | 2014 | 2213 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2001 | 3604 | 0.020 |
Why?
|
| Extremities | 1 | 2014 | 867 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2014 | 909 | 0.020 |
Why?
|
| Disease Progression | 2 | 2015 | 13505 | 0.020 |
Why?
|
| Transgenes | 2 | 2003 | 1006 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2016 | 1957 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2002 | 3870 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2000 | 4437 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12156 | 0.020 |
Why?
|
| Radiography | 3 | 2004 | 6965 | 0.020 |
Why?
|
| Risk Assessment | 3 | 2022 | 24086 | 0.020 |
Why?
|
| Stem Cells | 1 | 2000 | 3525 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6545 | 0.020 |
Why?
|
| Prosthesis Design | 2 | 2003 | 2127 | 0.020 |
Why?
|
| Recurrence | 1 | 2016 | 8487 | 0.010 |
Why?
|
| Aged, 80 and over | 5 | 2015 | 58947 | 0.010 |
Why?
|
| Critical Illness | 1 | 2016 | 2709 | 0.010 |
Why?
|
| Boston | 1 | 2016 | 9282 | 0.010 |
Why?
|
| Survival Rate | 2 | 2012 | 12806 | 0.010 |
Why?
|
| Foreign-Body Reaction | 1 | 2003 | 158 | 0.010 |
Why?
|
| Brachiocephalic Trunk | 1 | 2002 | 41 | 0.010 |
Why?
|
| Tibial Arteries | 1 | 2002 | 60 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2003 | 127 | 0.010 |
Why?
|
| Celiac Artery | 1 | 2002 | 65 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2003 | 119 | 0.010 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2002 | 95 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 3335 | 0.010 |
Why?
|
| Subclavian Artery | 1 | 2002 | 133 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2017 | 4786 | 0.010 |
Why?
|
| Graft Rejection | 2 | 2005 | 4423 | 0.010 |
Why?
|
| Cohort Studies | 3 | 2014 | 41317 | 0.010 |
Why?
|
| Mesenteric Arteries | 1 | 2002 | 178 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8553 | 0.010 |
Why?
|
| Logistic Models | 1 | 2015 | 13311 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2003 | 941 | 0.010 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2002 | 231 | 0.010 |
Why?
|
| Osteoarthritis, Knee | 1 | 2011 | 1234 | 0.010 |
Why?
|
| Sutures | 1 | 2003 | 294 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2005 | 2120 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2003 | 544 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2015 | 9283 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2002 | 848 | 0.010 |
Why?
|
| Incidence | 2 | 2012 | 21378 | 0.010 |
Why?
|
| Massachusetts | 1 | 2012 | 8805 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2000 | 749 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14656 | 0.010 |
Why?
|
| Metals | 1 | 2003 | 736 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 2002 | 951 | 0.010 |
Why?
|
| Length of Stay | 1 | 2012 | 6472 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2005 | 15827 | 0.010 |
Why?
|
| Pelvis | 1 | 2001 | 743 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 4773 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4573 | 0.010 |
Why?
|
| Graft Survival | 1 | 2005 | 3793 | 0.010 |
Why?
|
| Reoperation | 1 | 2004 | 4292 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2000 | 1602 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2012 | 54263 | 0.010 |
Why?
|
| Cell Division | 1 | 2000 | 4462 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 8314 | 0.010 |
Why?
|
| Acute Disease | 1 | 2002 | 7268 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 13456 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2001 | 5201 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 12532 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 17628 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2000 | 5873 | 0.010 |
Why?
|
| Patient Selection | 1 | 2001 | 4276 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 11064 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2000 | 3483 | 0.010 |
Why?
|
| Sepsis | 1 | 2001 | 2594 | 0.000 |
Why?
|
| Gene Expression | 1 | 2000 | 7592 | 0.000 |
Why?
|
| United States | 1 | 2014 | 72363 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 2000 | 18968 | 0.000 |
Why?
|
| Adult | 2 | 2014 | 219847 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 18134 | 0.000 |
Why?
|
| Animals | 1 | 2003 | 167940 | 0.000 |
Why?
|